ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,033, issued on April 22, was assigned to ABILITY PHARMACEUTICALS S.L. (Cerdanyola del Valles, Spain).
"Pharmaceutical combination for the treatment of a cancer" was invented by Carles Domenech Garcia (Cerdanyola del Valles, Spain), Jose Alberto Alfon Coriat (Cerdanyola del Valles, Spain), Hector Perez Montoyo (Cerdanyola del Valles, Spain), Miguel Francisco Segura Ginard (Cerdanyola del Valles, Spain) and Jose Miguel Lizcano De Vega (Cerdanyola del Valles, Spain).
According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical combination comprising (A): a polyunsaturated fatty acid and (B): a chemotherapeutic agent compound for the simultaneous, separ...